Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Menstrual Cycle Maintenance and Quality of Life: A Prospective Study

Active, not recruiting

Conditions: Breast Cancer
Menstrual Cycle
Amenorrhea

Interventions: Other: Questionnaire

First Posted Date: 2008-01-10

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 810

Registration Number: NCT00589654

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

Completed

Conditions: Breast Cancer

Interventions: Other: Blood test
Other: Questionnaire

First Posted Date: 2008-01-10

Last Posted Date: 2021-12-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 383

Registration Number: NCT00590109

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

Phase 2

Completed

Conditions: Lung Cancer
Non-small Cell Lung Cancer
Bronchioloalveolar Cancer

Interventions: Drug: Gefitinib

First Posted Date: 2008-01-08

Last Posted Date: 2016-01-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 65

Registration Number: NCT00588445

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function

Not Applicable

Completed

Conditions: Vaginal Cancer

Interventions: Behavioral: QOL

First Posted Date: 2008-01-08

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT00588081

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Phase 2

Completed

Conditions: Brain Metastasis
Bladder Cancer
Breast Cancer
Colon Cancer
Melanoma
Cervical Cancer
HEENT Cancer
Prostate Cancer
Sarcoma
Lung Cancer

Interventions: Radiation: Stereotactic Radiosurgery

First Posted Date: 2008-01-08

Last Posted Date: 2016-02-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT00587964

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL

Phase 2

Completed

Conditions: Lymphoma
B-cell Non-Hodgkin's Lymphoma

Interventions: Drug: Rituximab, Ifosfamide, Carboplatin, VP-16, Mesna, G-CSF, Stem Cell Transplant

First Posted Date: 2008-01-08

Last Posted Date: 2015-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT00588094

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone

First Posted Date: 2008-01-08

Last Posted Date: 2025-03-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 300

Registration Number: NCT00588185

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States

and more 4 locations

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Other: Placebo
Drug: anastrozole

First Posted Date: 2008-01-08

Last Posted Date: 2015-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT00588003

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Phase 2

Completed

Conditions: Melanoma
Skin Cancer
Cancer

Interventions: Drug: Temozolomide

First Posted Date: 2008-01-08

Last Posted Date: 2016-02-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT00588341

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

The Communication of Genetic Risk to Adolescent Daughters of Women With Breast Cancer

Completed

Conditions: Counseling
Breast Cancer

Interventions: Behavioral: focus group & questionaire

First Posted Date: 2008-01-08

Last Posted Date: 2017-01-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT00588705

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy